AVR anteris technologies global corp.

Ann: DurAVR First in Human Study 12 Month Results, page-9

  1. 5,797 Posts.
    lightbulb Created with Sketch. 963
    Hi all .. If memory serves me correctly. None of these patients would have qualified to be a part of any specific trial. Their health situation was not suitable- from my understanding. So taking that into consideration, if I am correct, this result is more than -outstanding.

    Thinking:- from my reads and research- you do your own- I may be a little off track here.
    -no more open heart surgery - maybe less costs ?
    -no long delay in hospital beds- A real positive benefit for the health system.
    -less danger of infection - only a small wound (near groin ????)
    -seemed to me some (or all) patients felt much better in a very short time after procedure (close to immediately ???) Better blood flow.
    -for use in younger patients
    -Not sure if any medicine - tablets are necessary after procedure - for extended period.
    -If necessary- way down track -another procedure can be performed.
    - May be others I missed

    Keep safe all - lots of interesting news to come.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.00
Change
-0.120(1.96%)
Mkt cap ! $92.99M
Open High Low Value Volume
$6.01 $6.08 $5.95 $42.27K 7.022K

Buyers (Bids)

No. Vol. Price($)
1 100 $6.01
 

Sellers (Offers)

Price($) Vol. No.
$6.08 260 1
View Market Depth
Last trade - 14.46pm 26/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.